UMIN-CTR Clinical Trial

Recruitment status Completed
Unique ID issued by UMIN UMIN000025898
Receipt No. R000016578
Official scientific title of the study Application of remifentanil to intravenous sedation in the patients compromised with severe gag reflex
Date of disclosure of the study information 2017/04/01
Last modified on 2017/01/30 (Ver. 1)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study Application of remifentanil to intravenous sedation in the patients compromised with severe gag reflex
Title of the study (Brief title) Application of remifentanil under intravenous sedation to the patients compromised with severe gag reflex
Region
Japan

Condition
Condition gag reflex in dental procedure
Classification by specialty
Anesthesiology Dental medicine Adult
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 The purpose of this study was to identify optimal remifentanil dose to avoid a severe gag reflex dureing dental procedure.
Basic objectives2 Safety,Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes Patient and dentist satisfaction by using remifentanil in intravenous sedation
Key secondary outcomes

Base
Study type Interventional

Study design
Basic design Parallel
Randomization Randomized
Randomization unit Individual
Blinding Open -no one is blinded
Control Dose comparison
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 3
Purpose of intervention Treatment
Type of intervention
Medicine
Interventions/Control_1 Respiratory rate is maintained more than 9 breaths/min. The dose of midazolam and propofol were titrated according to the OAA/S Scale (Observers Assessment of Alertness/Sedation Scale).
Interventions/Control_2 In addition to Intervention 1, remifentanil(0.06micro-g/kg/min)is additionally infused.
Interventions/Control_3 In addition to Intervention 1, remifentanil(0.08micro-g/kg/min)is additionally infused.
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit
80 years-old >=
Gender Male and Female
Key inclusion criteria Physical status of the enrolled patients are American Society of Anesthesiologists(ASA) class 1-2, aged 20 years old or above, who cannot torelate dental treatment because of gag reflex.
Key exclusion criteria Exclusion criteria included allergies to remifentanil, fentanyl-related, propofol and midazolam, used than other analgesic drug and sedative drug propofol and remifentanil, ASA class 3 or over, child and disability person.
Target sample size 48

Research contact person
Name of lead principal investigator Mutsumi Nonaka
Organization Showa University School of Dentistry
Division name Depertment of perioperative Medicine, Division of Anesthesiology
Address 2-1-1 Kitasenzoku, Ota-ku, Tokyo
TEL 03-3787-1151
Email nmutsumi@dent.showa-u.ac.jp

Public contact
Name of contact person Mutsumi Nonaka
Organization Showa University School of Dentistry
Division name Depertment of perioperative Medicine, Division of Anesthesiology
Address 2-1-1 Kitasenzoku, Ota-ku, Tokyo
TEL 03-3787-1151
Homepage URL
Email nmutsumi@dent.showa-u.ac.jp

Sponsor
Institute Depertment of perioperative Medicine, Division of Anesthesiology,Showa University School of Dentistry
Institute
Department

Funding Source
Organization None
Organization
Division
Category of Funding Organization Self funding
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2017 Year 04 Month 01 Day

Progress
Recruitment status Completed
Date of protocol fixation
2014 Year 03 Month 25 Day
Anticipated trial start date
2014 Year 04 Month 08 Day
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Related information
URL releasing protocol
Publication of results Unpublished
URL releasing results
Results
Other related information

Management information
Registered date
2017 Year 01 Month 30 Day
Last modified on
2017 Year 01 Month 30 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000016578